Location History:
- Gaithersburg, MD (US) (1995 - 2000)
- North Potomac, MD (US) (2005)
- N. Potomac, MD (US) (2012)
Company Filing History:
3 out of 1,217 
2 out of 2,320 
2 out of 1,982 
Years Active: 1995-2012
Title: The Innovative Contributions of Sharon M Wahl
Introduction
Sharon M Wahl is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biomedical research, particularly in the area of HIV-1 replication and retroviral infections. With a total of 7 patents to her name, her work has had a profound impact on the development of therapeutic strategies against viral infections.
Latest Patents
One of her latest patents is titled "Methods and compositions for the inhibition of HIV-1 replication." This invention focuses on methods and compositions aimed at attenuating HIV-1 replication in human cells, especially in human macrophages. The invention emphasizes the use of inhibitors of P21 (CDKNIA) expression to reduce such replication. Additionally, it explores the application of antisense P21 oligonucleotides, siRNA, and/or 2-cyano-3,12-dioxooleana-1,9-dien28-oic (CDDO) for this purpose. Another significant patent is "Inhibition of retrovirus infection," which provides methods and pharmaceutical compositions to prevent retroviral infections of host cells. This invention specifically addresses the prevention of HIV infection in human cells through the use of serine leukocyte protease inhibitor (SLPI).
Career Highlights
Throughout her career, Sharon M Wahl has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the University of Minnesota. Her research has been pivotal in advancing our understanding of viral infections and developing potential treatments.
Collaborations
Sharon has collaborated with notable individuals in her field, including James B McCarthy and Leo T Furcht. These collaborations have further enriched her research and contributed to her innovative work.
Conclusion
Sharon M Wahl's contributions to the field of biomedical research, particularly in the context of HIV-1 replication and retroviral infections, highlight her role as a leading inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving therapeutic options for viral infections.